← back to search

Isabelle Staropoli

Institut Pasteur · FR
Area of research
Infectious Diseases · Virology
Research interest
Research interests include SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies, HIV Research and Treatment, and SARS-CoV-2 detection and testing.
h-index
40
citations
10,191
works
121
NIH funding
primary concept
Medicine
email

Recent publications

Detection and characterization of single SARS-CoV-2 viral particles by flow virometry
2026cited by 0position: contributordoi
TMPRSS2 reduces antibody recognition of SARS-CoV-2 spike
2026cited by 0position: contributordoi
Epitope-Driven Polyfunctional Divergence of SARS-CoV-2 RBD Antibodies
2025cited by 0position: contributordoi
Distinct evolution of SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 lineages combining increased fitness and antibody evasion
Nature Communications 2024cited by 237position: middledoi
Modeling memory B cell responses in a lymphoid organ-chip to evaluate mRNA vaccine boosting.
2024cited by 24position: contributordoi
Resistance of Omicron subvariants BA.2.75.2, BA.4.6, and BQ.1.1 to neutralizing antibodies
Nature Communications 2023cited by 196position: middledoi
Serum neutralization of SARS-CoV-2 Omicron sublineages BA.1 and BA.2 in patients receiving monoclonal antibodies
Nature Medicine 2022cited by 309position: middledoi
Potent human broadly SARS-CoV-2–neutralizing IgA and IgG antibodies effective against Omicron BA.1 and BA.2
The Journal of Experimental Medicine 2022cited by 66position: middledoi
Longitudinal analysis of serum neutralization of SARS-CoV-2 Omicron BA.2, BA.4, and BA.5 in patients receiving monoclonal antibodies
Cell Reports Medicine 2022cited by 58position: middledoi
Potent human broadly SARS-CoV-2-neutralizing IgA and IgG antibodies effective against Omicron BA.1 and BA.2.
2022cited by 58position: contributordoi
Considerable escape of SARS-CoV-2 Omicron to antibody neutralization
Nature 2021cited by 1,606position: middledoi
Considerable escape of SARS-CoV-2 Omicron to antibody neutralization
Nature 2021cited by 213position: middledoi
A comparison of four serological assays for detecting anti–SARS-CoV-2 antibodies in human serum samples from different populations
Science Translational Medicine 2020cited by 273position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 4 papers (2024–2026)Olivier Schwartz · Université Paris Cité4 papers (2024–2026)Timothée Bruel · Antea Group (France)3 papers (2025–2026)Hugo Mouquet · Montreal Heart Institute3 papers (2025–2026)Cyril Planchais · Institut thématique Immunologie, inflammation, infectiologie et microbiologie3 papers (2025–2026)Olivier Schwartz · Institut Pasteur2 papers (2023–2024)Thiérry Prazuck · Université d'Orléans2 papers (2023–2024)Etienne Simon‐Lorière · Centre National de la Recherche Scientifique2 papers (2023–2024)Hélène Péré · Paris Cardiovascular Research Center2 papers (2023–2024)Laurent Hocqueloux · Hôpital Saint-André2 papers (2023–2024)Matthieu Prot · Centre National de la Recherche Scientifique2 papers (2023–2024)Pierre Rosenbaum · 2 papers (2025–2026)Andrea Cottignies-Calamarte · Institut Pasteur2 papers (2026–2026)David Veyer · Department of Virology2 papers (2023–2024)Françoise Porrot · Institut Pasteur2 papers (2023–2024)Florence Guivel‐Benhassine · Centre National de la Recherche Scientifique2 papers (2023–2024)Delphine Planas · Institut Pasteur2 papers (2023–2024) · 1 papers (2023–2023)Flora Donati · Université Paris Cité1 papers (2024–2024)Hugo Mouquet · Institut Pasteur1 papers (2023–2023)